Merck & Co., Inc. (MRK) Income statement
Top 20 of 30 line items reported by MRK · 250+ in the full API →
Merck & Co., Inc. (MRK) · Income Statement
Consolidated Statements of Operations
Annual · In millions USD, except per-share data · Latest filed Feb 24, 2026 · FY ends Dec 31
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Total Revenue | $65,011 | $64,168 | $60,115 | $59,283 | |
| Cost of Revenue | 16,382 | 15,193 | 16,126 | 17,411 | |
| Gross Profit | $48,629 | $48,975 | $43,989 | $41,872 | |
| Other Operating Expenses | 26,522 | 28,754 | 41,035 | 23,590 | |
| Total Operating Expenses | 42,904 | 43,947 | 57,161 | 41,001 | |
| Operating Income | $22,107 | $20,221 | $2,954 | $18,282 | |
| EBIT (Earnings Before Interest & Tax) | 22,107 | 20,221 | 2,954 | 18,282 | |
| Add: Depreciation & Amortization | 5,845 | 4,504 | 3,828 | 3,924 | |
| EBITDA (Non-GAAP) | $27,952 | $24,725 | $6,782 | $22,206 | |
| Interest Income | 343 | 415 | 365 | 157 | |
| Interest Expense | -1,357 | -1,271 | -1,146 | -962 | |
| Investment Gains (Losses) | 368 | 14 | 340 | (1,419) | |
| Foreign Exchange Gain (Loss) | (323) | (227) | (370) | (237) | |
| Non-Operating Income (Expense) | $(969) | $(1,069) | $(811) | $(2,461) | |
| Income Before Taxes (EBT) | $21,067 | $19,936 | $1,889 | $16,444 | |
| Provision for Income Taxes | 2,804 | 2,803 | 1,512 | 1,918 | |
| Effective Tax Rate | 13.3% | 14.1% | 80% | 11.7% | |
| Net Income | $18,254 | $17,117 | $365 | $14,519 | |
| Diluted Earnings Per Share | $7.28 | $6.74 | $0.14 | $5.71 | |
| Gross Margin | 74.8% | 76.3% | 73.2% | 70.6% | |
10 more line items available via the API
Research & DevelopmentSales, General & AdministrativeAsset Impairment ChargesGain (Loss) on Equity SecuritiesShares OutstandingDiluted Shares OutstandingBasic Earnings Per ShareOperating MarginOther OpEx MarginNet Margin
Ask your agent:
get_financialsAPIGET /api/v1/companies/MRK/income-statement?period=annual&years=8Docs →